Details for New Drug Application (NDA): 212544
✉ Email this page to a colleague
The generic ingredient in OSELTAMIVIR PHOSPHATE is oseltamivir phosphate. There are eight drug master file entries for this compound. Thirty-five suppliers are listed for this compound. Additional details are available on the oseltamivir phosphate profile page.
Summary for 212544
| Tradename: | OSELTAMIVIR PHOSPHATE |
| Applicant: | Msn |
| Ingredient: | oseltamivir phosphate |
| Patents: | 0 |
Pharmacology for NDA: 212544
| Mechanism of Action | Neuraminidase Inhibitors |
Medical Subject Heading (MeSH) Categories for 212544
Suppliers and Packaging for NDA: 212544
| Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
|---|---|---|---|---|---|---|---|---|
| OSELTAMIVIR PHOSPHATE | oseltamivir phosphate | CAPSULE;ORAL | 212544 | ANDA | Preferred Pharmaceuticals Inc. | 68788-8309 | 68788-8309-1 | 1 BLISTER PACK in 1 CARTON (68788-8309-1) / 10 CAPSULE in 1 BLISTER PACK |
| OSELTAMIVIR PHOSPHATE | oseltamivir phosphate | CAPSULE;ORAL | 212544 | ANDA | Novadoz Pharmaceuticals LLC | 72205-042 | 72205-042-11 | 1 BLISTER PACK in 1 CARTON (72205-042-11) / 10 CAPSULE in 1 BLISTER PACK |
Profile for product number 001
| Active Rx/OTC/Discontinued: | RX | Dosage: | CAPSULE;ORAL | Strength | EQ 30MG BASE | ||||
| Approval Date: | May 20, 2020 | TE: | AB | RLD: | No | ||||
Profile for product number 002
| Active Rx/OTC/Discontinued: | RX | Dosage: | CAPSULE;ORAL | Strength | EQ 45MG BASE | ||||
| Approval Date: | May 20, 2020 | TE: | AB | RLD: | No | ||||
Profile for product number 003
| Active Rx/OTC/Discontinued: | RX | Dosage: | CAPSULE;ORAL | Strength | EQ 75MG BASE | ||||
| Approval Date: | May 20, 2020 | TE: | AB | RLD: | No | ||||
Complete Access Available with Subscription
